Nervous System

The diagnosis of multiple sclerosis disease is based on the presence of: at least two different lesions (plaques or scars) in the white matter of the CNS (the space dissemination criterion); at least two different episodes in the disease course (the time dissemination criterion); chronic inflammation of the CNS, as determined by analysis of the […]

There are several multiple sclerosis risks that are associated with MS: Age. The onset of MS usually occurs between 20 and 40 years. Sex. Women are more likely to have relapsing-remitting MS. Family history. If one of your parents or siblings has had MS, you are at higher risk of developing the disease. Certain infections. […]

There are no specific MS tests, doctors use a differential diagnosis, which consists of eliminating other possible diagnoses. Multiple sclerosis diagnosis consists of: a thorough medical history and examination; blood tests; tests for specific biomarkers associated with multiple sclerosis, which are currently under development; spinal tap (lumbar puncture), in which a small sample of cerebrospinal […]

Medications There are prescribed medications that support managing ms symptoms, but in the case of DMTs, a patient should adjust to a schedule. Diet and exercise Regular exercise improves physical and mental health, so it is usually advised to MS patients to join a special yoga class or a swimming pool. It is also best […]

Fatigue MS fatigue occurs in about 80% of MS patients, according to the National Multiple Sclerosis Society (NMSS). Difficulty walking Multiple sclerosis difficulty walking can be caused by: numbness in legs or feet; troubled balance; muscle weakness; muscle spasticity; troubled vision. Difficulty walking can result in injuries if you fall. Vision problems MS vision problems […]

MS progression treatment: Ocrelizumab (Ocrevus) is the only FDA-approved disease-modifying therapy (DMT). It is prescribed to patients with primary-progressive MS, and those receiving the progressive MS treatment are slightly less likely to progress than untreated. As most of the immune response associated with MS occurs in the early stages of the disease, aggressive treatment as […]

Multiple sclerosis (MS) is an immune-mediated inflammatory disease that attacks myelinated axons in the central nervous system, destroying the myelin and the axon in variable degrees and producing significant physical disability. To understand what is MS, it is critical to understand the structure of neurons. Axons are key parts of a neuron, they transfer electrical […]

Typical MS treatment targets recovery from attacks, reducing symptoms, and slowing the progression. Sometimes, no MS treatment is needed. However, one cure doesn’t exist yet. There are several treatments for MS attacks Corticosteroids like oral prednisone and intravenous methylprednisolone are proved to be effective in lowering nerve inflammation. There are several possible side effects: insomnia, […]

MS subtypes are considered important during prognosis and treatment: relapsing-remitting MS (RRMS), primary progressive MS (PPMS), secondary progressive MS (SPMS), progressive relapsing MS (PRMS). 1. What is RRMS? Relapsing-remitting MS is associated with unpredictable acute attacks followed by remission periods, new or increasing neurologic symptoms. It usually starts in the patient’s 20s or 30s. RRMS […]

Primary progressive multiple sclerosis (PPMS) is associated with symptoms that worsen over time. The disease can be “active” if there are new symptoms or changes on an MRI scan, or “not active.”The most common primary progressive MS symptoms lead to troubled mobility, and they can include: changes in gait; stiff arms and legs; heavy legs; […]